Trial
NCT05889793
Evaluating Emetine for Viral Outbreaks (EVOLVE)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
Nepal Health Research Council; Bharatpur Hospital Chitwan; Stony Brook University; Rutgers University
Condition
COVID-19
Intervention
Emetine Hydrochloride
Why stopped
The study was terminated due to insufficient participant enrollment resulting from a lower-than-expected number of COVID-19 cases
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-23